Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
33.65-1.83 (-5.16%)
At close: 04:00PM EDT
33.65 0.00 (0.00%)
After hours: 05:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.65
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 359.68
52 Week Low 327.36
50-Day Moving Average 333.06
200-Day Moving Average 338.39

Share Statistics

Avg Vol (3 month) 3905.03k
Avg Vol (10 day) 31.78M
Shares Outstanding 558.91M
Implied Shares Outstanding 6N/A
Float 851.59M
% Held by Insiders 112.61%
% Held by Institutions 185.97%
Shares Short (Apr 28, 2022) 42.91M
Short Ratio (Apr 28, 2022) 44.17
Short % of Float (Apr 28, 2022) 46.53%
Short % of Shares Outstanding (Apr 28, 2022) 44.92%
Shares Short (prior month Mar 30, 2022) 43.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-7,306.74%

Management Effectiveness

Return on Assets (ttm)-14.46%
Return on Equity (ttm)-24.09%

Income Statement

Revenue (ttm)6.31M
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)-99.90%
Gross Profit (ttm)-43.99M
EBITDA -456.73M
Net Income Avi to Common (ttm)-457.89M
Diluted EPS (ttm)11.06
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.74B
Total Cash Per Share (mrq)29.5
Total Debt (mrq)18.43M
Total Debt/Equity (mrq)1.07
Current Ratio (mrq)21.14
Book Value Per Share (mrq)31.20

Cash Flow Statement

Operating Cash Flow (ttm)-378.18M
Levered Free Cash Flow (ttm)-195.97M
Advertisement
Advertisement